The Mayo Clinic Center for Tuberculosis, a regional training and consultation center at Mayo Clinic's campus in Rochester, Minn, is today launching a new medical journal, the Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. The online journal is published by Elsevier.
"We believe that the Journal of Clinical Tuberculosis and Other Mycobacterial Diseases fills an unmet need by providing a platform for the dissemination of the results of clinically relevant research," say the editors in their inaugural editorial for the publication. They also cite the continue spread of tuberculosis as a global health problem, making it the second greatest cause of death from infectious diseases after HIV.
"We are very excited that we are launching this journal on World TB Day and hope that it will effectively advance new knowledge that will ultimately help end this terrible disease," says Editor-in-Chief Zelalem Temesgen, M.D [Za-La-Lum Tah-mezg-in]. Two other Mayo Clinic physician-researchers, Stacey Rizza, M.D. and John Wilson, M.D., will serve as associate editors. All three are members of the Division of Infectious Diseases at Mayo Clinic and members of the tuberculosis center. An editorial board composed of leading experts in the field from around the globe has already been established to help advance the journal's mission.
The international journal will publish research on all aspects of tuberculosis, including epidemiology, clinical investigation, transmission, diagnosis, treatment, drug-resistance, and public policy. It will also publish articles related to non-tuberculous mycobacteria, including epidemiology, microbiology, immunology, and clinical descriptions of infections, diagnosis, treatment, and drug resistance.
In addition to original research, the journal will feature editorial commentaries, review articles, case reports, invited key reviews, and articles on practice management. The editors hope to reach and involve clinicians and scientists across such fields as infectious diseases, pulmonology, dermatology, thoracic surgery, urology, pharmacology and microbiology, as well as public health professionals and policy makers. The journal will begin publishing articles individually as they are received, peer-reviewed and accepted.
New $5.8 million grant aims to transform the global landscape of TB research